Literature DB >> 16236741

Clinical practice. Management of newly diagnosed HIV infection.

Scott M Hammer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16236741     DOI： 10.1056/NEJMcp051203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Primary HIV.

Authors:  J Fox; J Weber; S Fidler
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

2.  Functional impairment of CD4 T cells despite normalization of T cell number in HIV.

Authors:  Kenneth S Knox; Richard B Day; Lisa M Kohli; Chadi A Hage; Homer L Twigg
Journal:  Cell Immunol       Date:  2006-10-30       Impact factor: 4.868

3.  A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease.

Authors:  Makoto Naganuma; Reiko Kunisaki; Naoki Yoshimura; Yoshiaki Takeuchi; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2012-10-05       Impact factor: 7.527

4.  Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.

Authors:  Roberto Di Santo; Roberta Costi; Alessandra Roux; Marino Artico; Antonio Lavecchia; Luciana Marinelli; Ettore Novellino; Lucia Palmisano; Mauro Andreotti; Roberta Amici; Clementina Maria Galluzzo; Lucia Nencioni; Anna Teresa Palamara; Yves Pommier; Christophe Marchand
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

5.  Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. fusion [corrected] inhibition.

Authors:  Sylvia Lee-Huang; Philip Lin Huang; Dawei Zhang; Jae Wook Lee; Ju Bao; Yongtao Sun; Young-Tae Chang; John Zhang; Paul Lee Huang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-24       Impact factor: 3.575

6.  Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults.

Authors:  Nils von Hentig; Brenda Dauer; Annette Haberl; Stefan Klauke; Thomas Lutz; Schlomo Staszewski; Sebastian Harder
Journal:  Eur J Clin Pharmacol       Date:  2007-07-31       Impact factor: 2.953

7.  Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy.

Authors:  Eric Lindzen; Valerie Jewells; Thomas Bouldin; Danielle Speer; Walter Royal; Silva Markovic-Plese
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

8.  Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.

Authors:  Thierry Buclin; Amalio Telenti; Rafael Perera; Chantal Csajka; Hansjakob Furrer; Jeffrey K Aronson; Paul P Glasziou
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

9.  Experiences of Screening for Human Immunodeficiency Virus, Viral Hepatitis B, and Viral Hepatitis C Infections at a Hospital in Thailand: Test Utilization and Outcomes.

Authors:  Veeravan Lekskulchai
Journal:  Med Sci Monit Basic Res       Date:  2019-10-10

Review 10.  Clinical Mimics: An Emergency Medicine-Focused Review of Influenza Mimics.

Authors:  Erica Simon; Brit Long; Alex Koyfman
Journal:  J Emerg Med       Date:  2017-02-16       Impact factor: 1.484
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.